TDAM USA’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $1.7M | Sell |
30,418
-490
| -2% | -$26.5K | 0.11% | 132 |
|
|
2021
Q3 | $1.48M | Hold |
30,908
| – | – | 0.1% | 133 |
|
|
2021
Q2 | $1.43M | Hold |
30,908
| – | – | 0.09% | 141 |
|
|
2021
Q1 | $1.04M | Sell |
30,908
-94
| -0.3% | -$3.35K | 0.06% | 166 |
|
|
2020
Q4 | $1.08M | Sell |
31,002
-24
| -0.1% | -$830 | 0.07% | 159 |
|
|
2020
Q3 | $1.08M | Sell |
31,026
-74
| -0.2% | -$2.47K | 0.07% | 150 |
|
|
2020
Q2 | $1.02M | Buy |
31,100
+142
| +0.5% | +$4.53K | 0.07% | 158 |
|
|
2020
Q1 | $932K | Buy |
30,958
+50
| +0.2% | +$1.49K | 0.08% | 162 |
|
|
2019
Q4 | $894K | Sell |
30,908
-644
| -2% | -$17.8K | 0.06% | 177 |
|
|
2019
Q3 | $816K | Buy |
31,552
+2,020
| +7% | +$51.1K | 0.06% | 182 |
|
|
2019
Q2 | $754K | Hold |
29,532
| – | – | 0.05% | 182 |
|
|
2019
Q1 | $772K | Buy |
29,532
+428
| +1% | +$10.5K | 0.05% | 178 |
|
|
2018
Q4 | $670K | Buy |
29,104
+2,804
| +11% | +$62.3K | 0.05% | 212 |
|
|
2018
Q3 | $626K | Hold |
26,300
| – | – | 0.04% | 239 |
|
|
2018
Q2 | $606K | Hold |
26,300
| – | – | 0.04% | 244 |
|
|
2018
Q1 | $648K | Hold |
26,300
| – | – | 0.04% | 228 |
|
|
2017
Q4 | $706K | Hold |
26,300
| – | – | 0.04% | 230 |
|
|
2017
Q3 | $633K | Sell |
26,300
-2,628
| -9% | -$59.4K | 0.04% | 240 |
|
|
2017
Q2 | $613K | Sell |
28,928
-6,402
| -18% | -$129K | 0.03% | 252 |
|
|
2017
Q1 | $606K | Sell |
35,330
-300
| -0.8% | -$5.22K | 0.03% | 259 |
|
|
2016
Q4 | $639K | Sell |
35,630
-2,000
| -5% | -$36.3K | 0.03% | 261 |
|
|
2016
Q3 | $783K | Sell |
37,630
-1,320
| -3% | -$32.7K | 0.04% | 249 |
|
|
2016
Q2 | $1.05M | Sell |
38,950
-2,550
| -6% | -$69.9K | 0.05% | 220 |
|
|
2016
Q1 | $1.12M | Sell |
41,500
-248
| -0.6% | -$6.64K | 0.05% | 210 |
|
|
2015
Q4 | $1.21M | Sell |
41,748
-1,302
| -3% | -$36K | 0.06% | 206 |
|
|
2015
Q3 | $1.17M | Hold |
43,050
| – | – | 0.06% | 201 |
|
|
2015
Q2 | $1.18M | Sell |
43,050
-2,100
| -5% | -$59K | 0.05% | 222 |
|
|
2015
Q1 | $1.21M | Sell |
45,150
-1,770
| -4% | -$40.8K | 0.05% | 228 |
|
|
2014
Q4 | $993K | Sell |
46,920
-5,000
| -10% | -$112K | 0.04% | 183 |
|
|
2014
Q3 | $1.24M | Hold |
51,920
| – | – | 0.05% | 167 |
|
|
2014
Q2 | $1.2M | Sell |
51,920
-1,330
| -2% | -$29.4K | 0.05% | 174 |
|
|
2014
Q1 | $1.22M | Hold |
53,250
| – | – | 0.05% | 167 |
|
|
2013
Q4 | $984K | Sell |
53,250
-1,430
| -3% | -$24.9K | 0.04% | 182 |
|
|
2013
Q3 | $925K | Sell |
54,680
-9,600
| -15% | -$161K | 0.04% | 143 |
|
|
2013
Q2 | $1.04M | Buy |
+64,280
| New | +$1.07M | 0.05% | 143 |
|
Other funds holding NVO
F
TDAM USA's NVO Position: Q4 2021 in Review
TDAM USA reduced its Novo Nordisk (NVO) stake by 1.6% in Q4 2021, selling an estimated $26.5K and leaving 30,418 shares worth $1.7M. The position accounts for 0.11% of the portfolio, ranked #132.
TDAM USA first reported a position in NVO in Q2 2013 and has held it in 35 quarters since. 887 funds tracked by Wall St. Rank hold NVO as of Q4 2021.
- TDAM USA held 30,418 shares of Novo Nordisk worth $1.7M as of Q4 2021.
- TDAM USA sold 490 Novo Nordisk shares in Q4 2021, an estimated $26.5K.
- Novo Nordisk made up 0.11% of TDAM USA's portfolio in Q4 2021, its #132 holding.
- TDAM USA first reported a position in Novo Nordisk in Q2 2013 and has held it in 35 quarters since.
- 887 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2021.
Based on TDAM USA's 13F filing for Q4 2021, filed 10 Feb 2022.